|
The device was not returned for evaluation.The electronic lot history record (elhr) and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other incidents.The investigation determined the reported difficulties in addition to the subsequent device embedded in tissue or plaque and unexpected medical intervention (additional therapy/non-surgical treatment) appear to be related to the operational context of the procedure.It is likely that the device interacted with the heavily calcified, heavily tortuous lesion during advancement and positioning, as resistance was noted, resulting in the reported difficult to advance/position, ultimately contributing to the reported stent dislodgement.A 3.5x15mm and a 3.5x18mm xience skypoint were used to compress the stent against the lesion.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|